Endo International CEO steps down; Campanelli named successor

Your Health Matters

(Reuters) – Endo International Plc said Chief Executive Rajiv De Silva had stepped down and would be replaced by generics division head Paul Campanelli, highlighting the drugmaker’s shift away from specialty branded drugs. Endo’s shares rose as much as 16 percent to $23.48 on Friday as the company also maintained its profit and revenue forecasts for the year. Campanelli joined Endo in 2015 following the company’s $8-billion acquisition of generic drugs maker Par Pharmaceutical, where he was CEO since 2012.
Go to Source

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave